| abstract |
Disclosed are compositions and methods relating to or derived from anti-CXCR3 antibodies. More specifically, fully human antibodies that bind to CXCR3, CXCR3 binding fragments and derivatives of such antibodies, and CXCR3 binding polypeptides comprising these fragments are disclosed. Furthermore, nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells containing such polynucleotides, methods for producing such antibodies, antibody fragments and derivatives and polypeptides, and Methods for using such antibodies, antibody fragments and derivatives and polypeptides are disclosed, including treating or diagnosing a subject having a CXCR3-related disorder or condition, including various inflammatory disorders and various cancers How to do. |